TY - JOUR T1 - Implications of delayed reopening in controlling the COVID-19 surge in Southern and West-Central USA JF - medRxiv DO - 10.1101/2020.12.01.20242172 SP - 2020.12.01.20242172 AU - Raj Dandekar AU - Emma Wang AU - George Barbastathis AU - Chris Rackauckas Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/12/03/2020.12.01.20242172.abstract N2 - In the wake of the rapid surge in the Covid-19 infected cases seen in Southern and West-Central USA in the period of June-July 2020, there is an urgent need to develop robust, data-driven models to quantify the effect which early reopening had on the infected case count increase. In particular, it is imperative to address the question: How many infected cases could have been prevented, had the worst affected states not reopened early? To address this question, we have developed a novel Covid-19 model by augmenting the classical SIR epidemiological model with a neural network module. The model decomposes the contribution of quarantine strength to the infection timeseries, allowing us to quantify the role of quarantine control and the associated reopening policies in the US states which showed a major surge in infections. We show that the upsurge in the infected cases seen in these states is strongly co-related with a drop in the quarantine/lockdown strength diagnosed by our model. Further, our results demonstrate that in the event of a stricter lockdown without early reopening, the number of active infected cases recorded on 14 July could have been reduced by more than 40% in all states considered, with the actual number of infections reduced being more than 100, 000 for the states of Florida and Texas. As we continue our fight against Covid-19, our proposed model can be used as a valuable asset to simulate the effect of several reopening strategies on the infected count evolution; for any region under consideration.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis effort was partially funded by the Intelligence Advanced Reseach Projects Activity (IARPA).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval was required for this study. All data used is publicly available.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code files and results are publicly available at https://github.com/RajDandekar/Reopening_ImpactSimulator_US_States https://github.com/RajDandekar/Reopening_ImpactSimulator_US_States ER -